Holly Krasa, MSc
CEO & Founder
Turns rabbit holes into results.
Holly is a global medical product development leader and health outcomes researcher who turns patient evidence into decisions that improve products, coverage, and policy. Her experience includes development of clinical outcome measures, biomarkers, first-in-disease, and first-of-kind treatments across brain, heart, kidney, and rare diseases. She has led at the organization, division, program, and product teams across industry and advocacy.
Board director, committee member, and consortia advisor. BS, Biology, University of Michigan. MS, Neurobiology and Physiology, Northwestern University.
Tangents welcome, sticky notes required.
